Topical CBD Ointment Efficacious For Psoriasis According To Thailand Researchers
Psoriasis is a skin condition that involves the development of a rash with itchy, scaly patches. The most common locations on the human body where psoriasis develops are the knees, elbows, butt, and scalp.
Unfortunately, it is still largely unknown what causes psoriasis. The current theory behind the cause seems to involve a combination of genetics and environmental issues, however, researchers are still trying to get to the bottom of it.
It is estimated that as much as two to three percent of the world’s population suffers from the condition. Fortunately, researchers in Thailand recently determined that CBD ointment may be an effective treatment for psoriasis. Below is more information about it via a NORML news release:
Bangkok, Thailand: The topical application of an ointment containing 2.5 percent CBD improves symptoms of psoriasis, according to the findings of a randomized, placebo-controlled study published in the Journal of the European Academy of Dermatology and Venerology.
A team of investigators affiliated with King Chulalongkorn University Hospital and Thammasat University Hospital in Thailand assessed the twice daily application of either CBD or placebo over a 12-week period in 51 patients with mild plaque-type psoriasis.
Areas treated with CBD showed significant improvements compared to areas treated with the placebo. Researchers did not identify any adverse effects attributable to the use of CBD.
“Our results indicated a trend of favorable response in the treatment with CBD, which has emerged as a therapeutic option for psoriasis,” authors concluded. “These outcomes will pave the way for future studies on [the] therapeutic effects of CBD.”
Prior studies have previously shown that CBD may reduce certain types of skin inflammation, including erythema, pruritis, and acne.
Full text of the study, “Topical cannabidiol-based treatment for psoriasis: A dual-centered randomized, placebo-controlled study,” appears in theJournal of the European Academy of Dermatology and Venerology.